{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T21:21:19Z","timestamp":1768339279080,"version":"3.49.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004006","name":"Bilimsel Ara\u015ftirma Projeleri Birimi, Istanbul \u00dcniversitesi","doi-asserted-by":"publisher","award":["55143"],"award-info":[{"award-number":["55143"]}],"id":[{"id":"10.13039\/501100004006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cerebral cavernous malformation (CCM) is a vascular lesion of the central nervous system that may lead to distinct symptoms among patients including cerebral hemorrhages, epileptic seizures, focal neurologic deficits, and\/or headaches. Disease-related mutations were identified previously in one of the three CCM genes: <jats:italic>CCM1<\/jats:italic>, <jats:italic>CCM2,<\/jats:italic> and <jats:italic>CCM3<\/jats:italic>. However, the rate of these mutations in sporadic cases is relatively low, and new studies report that mutations in CCM genes may not be sufficient to initiate the lesions. Despite the growing body of research on CCM, the underlying molecular mechanism has remained largely elusive. In order to provide a novel insight considering the specific manifested symptoms, CCM patients were classified into two groups (as Epilepsy and Hemorrhage). Since the studied patients experience various symptoms, we hypothesized that the underlying cause for the disease may also differ between those groups. To this end, the respective transcriptomes were compared to the transcriptomes of the control brain tissues and among each other. This resulted into the identification of\u00a0the\u00a0differentially expressed\u00a0coding genes\u00a0and\u00a0the delineation of the corresponding differential expression profile for each comparison. Notably, some of those differentially expressed genes were previously implicated in epilepsy, cell structure formation, and cell metabolism. However, no <jats:italic>CCM1-3<\/jats:italic> gene deregulation was detected. Interestingly, we observed that when compared to the normal controls, the expression of some identified genes was only significantly altered either in Epilepsy (<jats:italic>EGLN1<\/jats:italic>, <jats:italic>ELAVL4<\/jats:italic>, and <jats:italic>NFE2l2<\/jats:italic>) or Hemorrhage (<jats:italic>USP22<\/jats:italic>, <jats:italic>EYA1, SIX1<\/jats:italic>, <jats:italic>OAS3<\/jats:italic>, <jats:italic>SRMS<\/jats:italic>) groups. To the best of our knowledge, this is the first such effort focusing on CCM patients with epileptic and hemorrhagic symptoms with the purpose of uncovering the potential CCM-related genes. It is also the first report that presents a gene expression dataset on Turkish CCM patients. The results suggest that the new candidate genes should be explored to further elucidate the CCM pathology. Overall, this work constitutes a step towards the identification of novel potential genetic targets for the development of possible future therapies.\n<\/jats:p>","DOI":"10.1038\/s41598-021-98647-9","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T10:21:04Z","timestamp":1632910864000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A novel insight into differential expression profiles of sporadic cerebral cavernous malformation patients with different symptoms"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6026-6052","authenticated-orcid":false,"given":"Hilal","family":"Eren Gozel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1502-1600","authenticated-orcid":false,"given":"K\u0131van\u00e7","family":"K\u00f6k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0925-8748","authenticated-orcid":false,"given":"Fatma","family":"Ozlen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8365-3338","authenticated-orcid":false,"given":"Cihan","family":"Isler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9453-4166","authenticated-orcid":false,"given":"Sadrettin","family":"Pence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,29]]},"reference":[{"key":"98647_CR1","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3171\/2011.8.JNS101241","volume":"116","author":"DD Cavalcanti","year":"2012","unstructured":"Cavalcanti, D. D. et al. Cerebral cavernous malformations: From genes to proteins to disease. J. Neurosurg. 116, 122\u2013132 (2012).","journal-title":"J. Neurosurg."},{"key":"98647_CR2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.bbrc.2014.10.105","volume":"455","author":"A Kumar","year":"2014","unstructured":"Kumar, A., Bhandari, A. & Goswami, C. Surveying genetic variants and molecular phylogeny of cerebral cavernous malformation gene, CCM3\/PDCD10. Biochem. Biophys. Res. Commun. 455, 98\u2013106 (2014).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"98647_CR3","volume-title":"Cavernous Malformations of the Brain and Spinal Cord","author":"G Lanzino","year":"2007","unstructured":"Lanzino, G. & Spetzler, R. Cavernous Malformations of the Brain and Spinal Cord (Thieme Publishers, 2007)."},{"key":"98647_CR4","first-page":"201","volume":"59","author":"E Trapani","year":"2015","unstructured":"Trapani, E. & Retta, S. F. Cerebral cavernous malformation (CCM) disease: From monogenic forms to genetic susceptibility factors. J. Neurosurg. Sci. 59, 201\u2013209 (2015).","journal-title":"J. Neurosurg. Sci."},{"key":"98647_CR5","first-page":"701","volume":"127","author":"KM Draheim","year":"2014","unstructured":"Draheim, K. M., Fisher, O. S., Boggon, T. J. & Calderwood, D. A. Cerebral cavernous malformation proteins at a glance. J. Cell Sci. 127, 701\u2013707 (2014).","journal-title":"J. Cell Sci."},{"key":"98647_CR6","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/mgg3.60","volume":"2","author":"S Spiegler","year":"2014","unstructured":"Spiegler, S. et al. High mutation detection rates in cerebral cavernous malformation upon stringent inclusion criteria: One-third of probands are minors. Mol. Genet. Genomic Med. 2, 176\u2013185 (2014).","journal-title":"Mol. Genet. Genomic Med."},{"key":"98647_CR7","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/ana.20947","volume":"60","author":"C Denier","year":"2006","unstructured":"Denier, C. et al. Genotype-phenotype correlations in cerebral cavernous malformations patients. Ann. Neurol. 60, 550\u2013556 (2006).","journal-title":"Ann. Neurol."},{"key":"98647_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10048-013-0362-0","volume":"14","author":"F Riant","year":"2013","unstructured":"Riant, F., Cecillon, M., Saugier-Veber, P. & Tournier-Lasserve, E. CCM molecular screening in a diagnosis context: Novel unclassified variants leading to abnormal splicing and importance of large deletions. Neurogenetics 14, 133. https:\/\/doi.org\/10.1007\/s10048-013-0362-0 (2013).","journal-title":"Neurogenetics"},{"key":"98647_CR9","doi-asserted-by":"publisher","DOI":"10.1086\/426952","volume-title":"Mutations Within the Programmed Cell Death 10 Gene Cause Cerebral Cavernous Malformations","author":"F Bergametti","year":"2005","unstructured":"Bergametti, F. et al. Mutations Within the Programmed Cell Death 10 Gene Cause Cerebral Cavernous Malformations (Elsevier, 2005)."},{"key":"98647_CR10","doi-asserted-by":"publisher","first-page":"704","DOI":"10.3390\/cells10030704","volume":"10","author":"G Riolo","year":"2021","unstructured":"Riolo, G., Ricci, C. & Battistini, S. Molecular genetic features of cerebral cavernous malformations (CCM) patients: An overall view from genes to endothelial cells. Cells 10, 704 (2021).","journal-title":"Cells"},{"key":"98647_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1911","author":"KJ Whitehead","year":"2009","unstructured":"Whitehead, K. J. et al. The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nature. https:\/\/doi.org\/10.1038\/nm.1911 (2009).","journal-title":"Nature"},{"key":"98647_CR12","doi-asserted-by":"publisher","first-page":"i2","DOI":"10.1083\/JCB1891OIA2","volume":"189","author":"R Stockton","year":"2010","unstructured":"Stockton, R. et al. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J. Cell Biol. 189, i2 (2010).","journal-title":"J. Cell Biol."},{"key":"98647_CR13","volume-title":"Cerebral Cavernous Malformations","author":"MT Caton","year":"2021","unstructured":"Caton, M. T. & Shenoy, V. S. Cerebral Cavernous Malformations (StatPearls Publishing, 2021)."},{"key":"98647_CR14","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s40478-019-0789-0","volume":"7","author":"J Koskim\u00e4ki","year":"2019","unstructured":"Koskim\u00e4ki, J. et al. Transcriptome clarifies mechanisms of lesion genesis versus progression in models of Ccm3 cerebral cavernous malformations. Acta Neuropathol. Commun. 7, 132 (2019).","journal-title":"Acta Neuropathol. Commun."},{"key":"98647_CR15","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1212\/01.WNL.0000118299.55857.BB","volume":"62","author":"DJ Verlaan","year":"2004","unstructured":"Verlaan, D. J. et al. CCM1 mutation screen of sporadic cases with cerebral cavernous malformations. Neurology 62, 1213\u20131215 (2004).","journal-title":"Neurology"},{"key":"98647_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/459253","volume":"2013","author":"R D\u2019Angelo","year":"2013","unstructured":"D\u2019Angelo, R. et al. Sporadic cerebral cavernous malformations: Report of further mutations of CCM genes in 40 Italian patients. BioMed Res. Int. 2013, 1\u20138 (2013).","journal-title":"BioMed Res. Int."},{"key":"98647_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-54845-0","volume":"9","author":"S Subhash","year":"2019","unstructured":"Subhash, S. et al. Transcriptome-wide profiling of cerebral cavernous malformations patients reveal important long noncoding RNA molecular signatures. Sci. Rep. 9, 1\u201313 (2019).","journal-title":"Sci. Rep."},{"key":"98647_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/antiox8010027","volume":"8","author":"L Cianfruglia","year":"2019","unstructured":"Cianfruglia, L. et al. Krit1 loss-of-function associated with cerebral cavernous malformation disease leads to enhanced s-glutathionylation of distinct structural and regulatory proteins. Antioxidants 8, 27 (2019).","journal-title":"Antioxidants"},{"key":"98647_CR19","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.126167","author":"J Koskim\u00e4ki","year":"2019","unstructured":"Koskim\u00e4ki, J. et al. Comprehensive transcriptome analysis of cerebral cavernous malformation across multiple species and genotypes. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.126167 (2019).","journal-title":"JCI Insight."},{"key":"98647_CR20","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.128577","author":"SB Lyne","year":"2019","unstructured":"Lyne, S. B. et al. Biomarkers of cavernous angioma with symptomatic hemorrhage. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.128577 (2019).","journal-title":"JCI Insight."},{"key":"98647_CR21","doi-asserted-by":"publisher","first-page":"165956","DOI":"10.1016\/j.bbadis.2020.165956","volume":"1866","author":"C Scimone","year":"2020","unstructured":"Scimone, C. et al. Transcriptome analysis provides new molecular signatures in sporadic cerebral cavernous malformation endothelial cells. Biochim. Biophys. Acta Mol. Basis Dis. 1866, 165956 (2020).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"98647_CR22","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1007\/s11357-020-00201-4","volume":"42","author":"J Koskim\u00e4ki","year":"2020","unstructured":"Koskim\u00e4ki, J. et al. Common transcriptome, plasma molecules, and imaging signatures in the aging brain and a Mendelian neurovascular disease, cerebral cavernous malformation. GeroScience 42, 1351\u20131363 (2020).","journal-title":"GeroScience"},{"key":"98647_CR23","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S1046-2023(03)00155-5","volume":"31","author":"GK Smyth","year":"2003","unstructured":"Smyth, G. K. & Speed, T. Normalization of cDNA microarray data. Methods 31, 265\u2013273 (2003).","journal-title":"Methods"},{"key":"98647_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gb-2004-5-10-r80","volume":"5","author":"RC Gentleman","year":"2004","unstructured":"Gentleman, R. C. et al. Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol. 5, 1\u201316 (2004).","journal-title":"Genome Biol."},{"key":"98647_CR25","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","volume":"20","author":"L Gautier","year":"2004","unstructured":"Gautier, L., Cope, L., Bolstad, B. M. & Irizarry, R. A. affy\u2013analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20, 307\u2013315 (2004).","journal-title":"Bioinformatics"},{"key":"98647_CR26","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/0-387-29362-0_23","volume-title":"Bioinformatics and Computational Biology Solutions Using R and Bioconductor","author":"GK Smyth","year":"2005","unstructured":"Smyth, G. K. limma: Linear models for microarray data. In Bioinformatics and Computational Biology Solutions Using R and Bioconductor (ed. Gentleman, R.) 397\u2013420 (Springer, 2005)."},{"key":"98647_CR27","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","volume":"4","author":"RA Irizarry","year":"2003","unstructured":"Irizarry, R. A. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249\u2013264 (2003).","journal-title":"Biostatistics"},{"key":"98647_CR28","volume-title":"Principal Component Analysis","author":"IT Jolliffe","year":"2002","unstructured":"Jolliffe, I. T. Principal Component Analysis (Springer, 2002)."},{"key":"98647_CR29","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1084\/jem.20110571","volume":"208","author":"G Boulday","year":"2011","unstructured":"Boulday, G. et al. Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice. J. Exp. Med. 208, 1835\u20131847 (2011).","journal-title":"J. Exp. Med."},{"key":"98647_CR30","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s10143-013-0456-z","volume":"36","author":"P Dammann","year":"2013","unstructured":"Dammann, P. et al. Two-hit mechanism in cerebral cavernous malformation? A case of monozygotic twins with a CCM1\/KRIT1 germline mutation. Neurosurg. Rev. 36, 483\u2013486 (2013).","journal-title":"Neurosurg. Rev."},{"key":"98647_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/cancers11010041","volume":"11","author":"S Berendsen","year":"2019","unstructured":"Berendsen, S. et al. Epilepsy associates with decreased HIF-1\u03b1\/STAT5b signaling in glioblastoma. Cancers 11, 41 (2019).","journal-title":"Cancers"},{"key":"98647_CR32","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s00432-010-0828-5","volume":"136","author":"Z Ding","year":"2010","unstructured":"Ding, Z. et al. Expression and significance of hypoxia-inducible factor-1 alpha and MDR1\/P-glycoprotein in human colon carcinoma tissue and cells. J. Cancer Res. Clin. Oncol. 136, 1697\u20131707 (2010).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"98647_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"Y Li","year":"2016","unstructured":"Li, Y. et al. Aberrant expression of miR-153 is associated with overexpression of hypoxia-inducible factor-1\u03b1 in refractory epilepsy. Sci. Rep. 6, 1\u201310 (2016).","journal-title":"Sci. Rep."},{"key":"98647_CR34","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.neuron.2012.07.009","volume":"75","author":"G Ince-Dunn","year":"2012","unstructured":"Ince-Dunn, G. et al. Neuronal elav-like (Hu) proteins regulate RNA splicing and abundance to control glutamate levels and neuronal excitability. Neuron 75, 1067\u20131080 (2012).","journal-title":"Neuron"},{"key":"98647_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.nbd.2015.02.011","volume":"78","author":"KD Winden","year":"2015","unstructured":"Winden, K. D., Bragin, A., Engel, J. & Geschwind, D. H. Molecular alterations in areas generating fast ripples in an animal model of temporal lobe epilepsy. Neurobiol. Dis. 78, 35\u201344 (2015).","journal-title":"Neurobiol. Dis."},{"key":"98647_CR36","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/ana.23940","volume":"74","author":"M Mazzuferi","year":"2013","unstructured":"Mazzuferi, M. et al. Nrf2 defense pathway: Experimental evidence for its protective role in epilepsy. Ann. Neurol. 74, 560\u2013568 (2013).","journal-title":"Ann. Neurol."},{"key":"98647_CR37","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.gene.2015.06.055","volume":"571","author":"Z Liu","year":"2015","unstructured":"Liu, Z. et al. Association of KEAP1 and NFE2L2 polymorphisms with temporal lobe epilepsy and drug resistant epilepsy. Gene 571, 231\u2013236 (2015).","journal-title":"Gene"},{"key":"98647_CR38","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1134\/S1022795417080051","volume":"53","author":"LN Porokhovnik","year":"2017","unstructured":"Porokhovnik, L. N. & Pisarev, V. M. Association of polymorphisms in NFE2L2 gene encoding transcription factor Nrf2 with multifactorial diseases. Russ. J. Genet. 53, 851\u2013864 (2017).","journal-title":"Russ. J. Genet."},{"key":"98647_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2216","author":"RG Lafreni\u00e8re","year":"2010","unstructured":"Lafreni\u00e8re, R. G. et al. A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura. Nature. https:\/\/doi.org\/10.1038\/nm.2216 (2010).","journal-title":"Nature"},{"key":"98647_CR40","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1186\/1744-8069-7-30","volume":"7","author":"A Tulleuda","year":"2011","unstructured":"Tulleuda, A. et al. TRESK channel contribution to nociceptive sensory neurons excitability: Modulation by nerve injury. Mol. Pain 7, 1744 (2011).","journal-title":"Mol. Pain"},{"key":"98647_CR41","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.bbrc.2008.01.008","volume":"367","author":"D Kang","year":"2008","unstructured":"Kang, D. et al. Lamotrigine inhibits TRESK regulated by G-protein coupled receptor agonists. Biochem. Biophys. Res. Commun. 367, 609\u2013615 (2008).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"98647_CR42","doi-asserted-by":"publisher","first-page":"37906","DOI":"10.18632\/oncotarget.5412","volume":"6","author":"RL Kosinsky","year":"2015","unstructured":"Kosinsky, R. L. et al. Usp22 deficiency impairs intestinal epithelial lineage specification in vivo. Oncotarget 6, 37906\u201337918 (2015).","journal-title":"Oncotarget"},{"key":"98647_CR43","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s12265-019-09909-x","volume":"13","author":"B Wang","year":"2020","unstructured":"Wang, B., Cai, W., Ai, D., Zhang, X. & Yao, L. The role of deubiquitinases in vascular diseases. J. Cardiovasc. Transl. Res. 13, 131\u2013141 (2020).","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"98647_CR44","doi-asserted-by":"publisher","DOI":"10.1242\/dev.174037","author":"E Koutelou","year":"2019","unstructured":"Koutelou, E. et al. USP22 controls multiple signaling pathways that are essential for vasculature formation in the mouse placenta. Development (Cambridge). https:\/\/doi.org\/10.1242\/dev.174037 (2019).","journal-title":"Development (Cambridge)."},{"key":"98647_CR45","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12964-019-0480-x","volume":"17","author":"K Zhang","year":"2019","unstructured":"Zhang, K. et al. Ubiquitin-specific protease 22 is critical to in vivo angiogenesis, growth and metastasis of non-small cell lung cancer. Cell Commun. Signal. 17, 167 (2019).","journal-title":"Cell Commun. Signal."},{"key":"98647_CR46","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ydbio.2017.09.027","volume":"431","author":"N Riddiford","year":"2017","unstructured":"Riddiford, N. & Schlosser, G. Six1 and Eya1 both promote and arrest neuronal differentiation by activating multiple Notch pathway genes. Dev. Biol. 431, 152\u2013167 (2017).","journal-title":"Dev. Biol."},{"key":"98647_CR47","first-page":"1","volume-title":"Advances in Anatomy Embryology and Cell Biology","author":"C Bolte","year":"2018","unstructured":"Bolte, C., Whitsett, J. A., Kalin, T. V. & Kalinichenko, V. V. Transcription factors regulating embryonic development of pulmonary vasculature. In Advances in Anatomy Embryology and Cell Biology Vol. 228 (ed. Parthasarathi, K.) 1\u201320 (Springer, 2018)."},{"key":"98647_CR48","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.ydbio.2011.02.031","volume":"353","author":"AHK El-Hashash","year":"2011","unstructured":"El-Hashash, A. H. K. et al. Six1 transcription factor is critical for coordination of epithelial, mesenchymal and vascular morphogenesis in the mammalian lung. Dev. Biol. 353, 242\u2013258 (2011).","journal-title":"Dev. Biol."},{"key":"98647_CR49","doi-asserted-by":"publisher","first-page":"165519","DOI":"10.1016\/j.bbadis.2019.07.013","volume":"1865","author":"J Li","year":"2019","unstructured":"Li, J. et al. Low fluid shear stress conditions contribute to activation of cerebral cavernous malformation signalling pathways. Biochim. Biophys. Acta Mol. Basis Dis. 1865, 165519 (2019).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"98647_CR50","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1007\/s12035-020-01872-y","volume":"57","author":"I Iwuchukwu","year":"2020","unstructured":"Iwuchukwu, I. et al. MicroRNA regulatory network as biomarkers of late seizure in patients with spontaneous intracerebral hemorrhage. Mol. Neurobiol. 57, 2346. https:\/\/doi.org\/10.1007\/s12035-020-01872-y (2020).","journal-title":"Mol. Neurobiol."},{"key":"98647_CR51","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.kint.2017.11.013","volume":"93","author":"A Bideak","year":"2018","unstructured":"Bideak, A. et al. The atypical chemokine receptor 2 limits renal inflammation and fibrosis in murine progressive immune complex glomerulonephritis. Kidney Int. 93, 826\u2013841 (2018).","journal-title":"Kidney Int."},{"key":"98647_CR52","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.15252\/embj.201488887","volume":"33","author":"KM Lee","year":"2014","unstructured":"Lee, K. M. et al. The chemokine receptors ACKR 2 and CCR 2 reciprocally regulate lymphatic vessel density. EMBO J. 33, 2564\u20132580 (2014).","journal-title":"EMBO J."},{"key":"98647_CR53","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1242\/dev.116418","volume":"142","author":"MA Trembley","year":"2015","unstructured":"Trembley, M. A., Velasquez, L. S., de Mesy Bentley, K. L. & Small, E. M. Myocardin-related transcription factors control the motility of epicardium-derived cells and the maturation of coronary vessels. Development (Cambridge) 142, 21\u201330 (2015).","journal-title":"Development (Cambridge)"},{"key":"98647_CR54","doi-asserted-by":"crossref","unstructured":"Krawczyk, K. K. et al. Myocardin family members drive formation of caveolae. PLoS ONE 10, 133931 (2015).","DOI":"10.1371\/journal.pone.0133931"},{"key":"98647_CR55","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.jalz.2016.08.001","volume":"13","author":"JG Geisler","year":"2017","unstructured":"Geisler, J. G., Marosi, K., Halpern, J. & Mattson, M. P. DNP, mitochondrial uncoupling, and neuroprotection: A little dab\u2019ll do ya. Alzheimer\u2019s Dementia 13, 582\u2013591 (2017).","journal-title":"Alzheimer\u2019s Dementia"},{"key":"98647_CR56","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.neuroscience.2013.10.026","volume":"256","author":"S Zahid","year":"2014","unstructured":"Zahid, S., Khan, R., Oellerich, M., Ahmed, N. & Asif, A. R. Differential S-nitrosylation of proteins in Alzheimer\u2019s disease. Neuroscience 256, 126\u2013136 (2014).","journal-title":"Neuroscience"},{"key":"98647_CR57","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.cellbi.2006.09.009","volume":"31","author":"H Zheng","year":"2007","unstructured":"Zheng, H. et al. Immunoglobulin alpha heavy chain derived from human epithelial cancer cells promotes the access of S phase and growth of cancer cells. Cell Biol. Int. 31, 82\u201387 (2007).","journal-title":"Cell Biol. Int."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98647-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98647-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98647-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T21:10:04Z","timestamp":1675717804000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98647-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,29]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["98647"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-98647-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,29]]},"assertion":[{"value":"18 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19351"}}